ST-Hebungsinfarkt: praktische Anwendung der aktuellen ESC-Leitlinie

Obwohl die Inzidenz des akuten ST-Hebungsinfarkts (STEMI) abnimmt, liegt sie europaweit immer noch sehr hoch. Die ESC hat letztes Jahr eine neue Leitlinie zur Behandlung von Patienten mit akutem STEMI veröffentlicht, die in diesem Beitrag aus einem praktischen, alltagsbezogenen Blickwinkel beleuchtet werden soll.

Schlüsselwörter

STEMI - Herzinfarkt - Koronarintervention

Key words

ST elevation acute myocardial infarction - percutaneous coronary intervention

• Literatur

• 1 Townsend N, Wilson L, Bhatnagar P. et al. Cardiovascular disease in Europe: epidemiological update 2016. Eur Heart J 2016; 37: 3232-3245 doi:10.1093/eurheartj/ehw334
• 2 Widimsky P, Wijns W, Fajadet J. et al. Reperfusion therapy for ST elevation acute myocardial infarction in Europe: description of the current situation in 30 countries. Eur Heart J 2010; 31: 943-957 doi:10.1093/eurheartj/ehp492
• 3 Ibanez B, James S, Agewall S. et al. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018; 39: 119-177 doi:10.1093/eurheartj/ehx393
• 4 Valgimigli M, Gagnor A, Calabro P. et al. Radial vs. femoral access in patients with acute coronary syndromes undergoing invasive management: a randomised multicentre trial. Lancet 2015; 385: 2465-2476 doi:10.1016/S0140-6736(15)60292-6
• 5 Jolly SS, Cairns JA, Yusuf S. et al. Randomized trial of primary PCI with or without routine manual thrombectomy. N Engl J Med 2015; 372: 1389-1398 doi:10.1056/NEJMoa1415098
• 6 Lagerqvist B, Frobert O, Olivecrona GK. et al. Outcomes 1 year after thrombus aspiration for myocardial infarction. N Engl J Med 2014; 371: 1111-1120 doi:10.1056/NEJMoa1405707
• 7 Jolly SS, James S, Dzavik V. et al. Thrombus Aspiration in ST-Segment-Elevation Myocardial Infarction: An Individual Patient Meta-Analysis: Thrombectomy Trialists Collaboration. Circulation 2017; 135: 143-152 doi:10.1161/CIRCULATIONAHA.116.025371
• 8 Sorajja P, Gersh BJ, Cox DA. et al. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur Heart J 2007; 28: 1709-1716 doi:10.1093/eurheartj/ehm184
• 9 Engstrom T, Kelbaek H, Helqvist S. et al. Complete revascularisation vs. treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3-PRIMULTI): an open-label, randomised controlled trial. Lancet 2015; 386: 665-671
• 10 Gershlick AH, Khan JN, Kelly DJ. et al. Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol 2015; 65: 963-972 doi:10.1016/j.jacc.2014.12.038
• 11 Smits PC, Abdel-Wahab M, Neumann FJ. et al. Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction. N Engl J Med 2017; 376: 1234-1244 doi:10.1056/NEJMoa1701067
• 12 Wald DS, Morris JK, Wald NJ. et al. Randomized trial of preventive angioplasty in myocardial infarction. N Engl J Med 2013; 369: 1115-1123 doi:10.1056/NEJMoa1305520
• 13 Goldberg RJ, Spencer FA, Gore JM. et al. Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation 2009; 119: 1211-1219 doi:10.1161/CIRCULATIONAHA.108.814947
• 14 Thiele H, Akin I, Sandri M. et al. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock. N Engl J Med 2017; 377: 2419-2432 doi:10.1056/NEJMoa1710261
• 15 Silvain J, Beygui F, Barthelemy O. et al. Efficacy and safety of enoxaparin versus unfractionated heparin during percutaneous coronary intervention: systematic review and meta-analysis. Br Med J 2012; 344: e553 doi:10.1136/bmj.e553
• 16 Capodanno D, Gargiulo G, Capranzano P. et al. Bivalirudin versus heparin with or without glycoprotein II b/III a inhibitors in patients with STEMI undergoing primary PCI: An updated meta-analysis of 10,350 patients from five randomized clinical trials. Eur Heart J Acute Cardiovasc Care 2016; 5: 253-262 doi:10.1177/2048872615572599
• 17 Valgimigli M, Bueno H, Byrne RA. et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2018; 39: 213-260 doi:10.1093/eurheartj/ehx419
• 18 Khera S, Kolte D, Gupta T. et al. Temporal Trends and Sex Differences in Revascularization and Outcomes of ST-Segment Elevation Myocardial Infarction in Younger Adults in the United States. J Am Coll Cardiol 2015; 66: 1961-1972 doi:10.1016/j.jacc.2015.08.865
• 19 Szummer K, Lundman P, Jacobson SH. et al. Relation between renal function, presentation, use of therapies and in-hospital complications in acute coronary syndrome: data from the SWEDEHEART register. J Int Med 2010; 268: 40-49 doi:10.1111/j.1365-2796.2009.02204.x